Category: Q2Syndicate content

Intuitive Surgical's Q2 profits tank but still beat expectations

July 22, 2014 by Arezu Sarvestani

Troubled Intuitive Surgical manages to blow away Wall Street's expectations, even as Q2 profits drop 35% year-over-year.

Intuitive Surgical's profits tank but still beat expectations

California device maker Intuitive Surgical (NSDQ:ISRG) got a major after-hours boost after reporting Q2 numbers that, while still down year-over-year, beat Wall Street's expectations by a mile.

Abbott raises full-year guidance on strong Q2, but medtech lags

July 18, 2014 by Arezu Sarvestani

Abbott Labs reports a strong 2nd quarter driven in large part by diagnostics, but the medical device segment took a hit in U.S. sales, leading to a pretty flat quarter.

Abbott raises full-year guidance, but medtech numbers fail to impress

Illinois-based Abbott (NYSE:ABT) released a 2nd-quarter earnings report showing some strong momentum, but the healthcare giant's medical device sector didn't fare so well.

GE Healthcare idles for another quarter

July 18, 2014 by Arezu Sarvestani

Industry giant GE posts another lackluster quarter for its healthcare business with flat sales and profits for Q2 and low expectations for the rest of the year.

GE Healthcare idles for another quarter

GE Healthcare (NYSE:GE) isn't terribly optimistic about its prospects for the rest of this year as its 2nd-quarter earnings report again shows softness in the U.S. dragging down total healthcare activity.

Stryker's Q2 earnings meet The Street

July 17, 2014 by Brad Perriello

Stryker Corp. reports 2nd-quarter earnings that meet Wall Street's expectations, despite flat profit growth on 7% sales growth.

Stryker's Q2 earnings meet The Street

Stryker (NYSE:SYK) said today that its 2nd-quarter earnings met expectations on Wall Street, despite flat profit growth, on 7% sales growth.

Baxter reports Q2 sales jump, narrows earnings guidance

July 17, 2014 by Brad Perriello

Baxter reports 2nd-quarter sales growth of more than 16% and beats earnings expectations, but narrows its full-year earnings guidance.

Baxter reports Q2 sales jump, narrows earnings guidance

Pharma delivers another beat & raise quarter for Johnson & Johnson

July 15, 2014 by Brad Perriello

Johnson & Johnson's pharmaceuticals division helps buoy the healthcare giant to another beat & raise quarter, but its medical device division again fails to meet expectations.

Pharma delivers another beat & raise quarter for Johnson & Johnson

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Biomet moves to Q4, 2014 black

July 10, 2014 by Brad Perriello

Biomet puts black ink back in the ledger for its fiscal 4th quarter and 2014, reporting double-digit adjusted profit increases for both periods.

Biomet moves to Q4, 2014 black

Biomet said yesterday that it put black ink back into its books for the fiscal 4th quarter and 2014, with adjusted profits rising by double digits.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp